Excellence in Service Award
Jingsong Wang, MD, PhD, is CEO of Harbour Biomed. Before founding HBM, he was the Head of China Research and Development and of Translational Medicine, Asia Pacific, for Sanofi. Dr. Wang joined Sanofi from Bristol-Myers Squibb, where he served in multiple roles including Director of Discovery Medicine and Clinical Pharmacology and Global Program Lead for pre-clinical and clinical assets. Dr. Wang completed his Clinical Rheumatology Fellowship and was an Attending Rheumatologist and faculty member at Brigham and Women's Hospital and Harvard Medical School. Dr. Wang earned his PhD in Molecular Pharmacology from China Pharmaceutical University and also completed a Molecular Immunology Research Fellowship at the Harvard School of Public Health.